Collaboration versus outsourcing: the need to think outside the box
- 1 December 2011
- journal article
- review article
- Published by Future Science Ltd in Future Medicinal Chemistry
- Vol. 3 (16), 1995-2020
- https://doi.org/10.4155/fmc.11.160
Abstract
As has been widely reviewed elsewhere, the pharmaceutical industry is experiencing an ‘innovation deficit’ as evidenced by the decline in new chemical entity output. This decline, compounded by increased costs and regulatory requirements highlights the need to significantly revise strategic options across the drug-discovery spectrum. Within such revision(s), much of the focus has been on outsourcing to reduce, or at least contain, costs, but if the underlying predominance of ‘closed collaborations’ is not challenged to allow better use of combined knowledge and, thus, move towards a more genuine collaborative process then a ‘numbers only’ approach will not bring medium-to-long-term survival. There are many problems to confront in evolving new sustainable strategies, a real need to think differently exists and should to be cultivated. This article reviews current outsourcing and collaboration strategies to provide a perspective on how great knowledge sharing could help revise the drug-discovery process.Keywords
This publication has 100 references indexed in Scilit:
- Organic synthesis toward small-molecule probes and drugsProceedings of the National Academy of Sciences of the United States of America, 2011
- The Alabama Drug Discovery Alliance: A Collaborative Partnership to Facilitate Academic Drug DiscoveryPharmaceutical Research, 2011
- Small Molecule Probes of Cellular Pathways and NetworksACS Chemical Biology, 2010
- Integration of Small-Molecule Discovery in Academic Biomedical ResearchMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- Organic Chemistry and Biology: Chemical Biology Through the Eyes of CollaborationThe Journal of Organic Chemistry, 2009
- The case for open‐access chemical biologyEMBO Reports, 2009
- NIMH Initiatives to Facilitate Collaborations Among Industry, Academia, and Government for the Discovery and Clinical Testing of Novel Models and Drugs for Psychiatric DisordersNeuropsychopharmacology, 2008
- Translational research: Crossing the valley of deathNature, 2008
- The innovative medicines initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patientsDrug Discovery Today, 2008
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007